Literature DB >> 9647675

Cyclic peptides as probes of the substrate binding site of the cytosolic tyrosine kinase, pp60c-src.

J S McMurray1, R J Budde, S Ke, N U Obeyesekere, W Wang, L Ramdas, C A Lewis.   

Abstract

A series of 48 cyclic peptides based on the amino acid sequence surrounding the autophosphorylation site of pp60(c-src) was synthesized and each was tested as both a substrate and an inhibitor of this protein tyrosine kinase. Starting with cyclo(Asp1-Asn2-Gln3-Tyr4-Ala5-Ala6-Arg7-Gln8-d- Phe9-Pro10) a six-amino-acid survey was performed at positions 1 through 8 to determine which positions were critical for affinity and phosphorylation and which amino acids produced the greatest activity. Our survey found that Arg7 was detrimental for binding and phosphorylation and that aromatic residues were preferred at this position. Further increases in affinity were obtained with hydrophobic residues at position 6 with the optimum for both affinity and phosphorylation being Phe. Changes on the "amino-terminal" side of Tyr4 resulted in reduced Vmax values, illustrating the requirement for acidic residues in peptidic tyrosine kinase substrates. The result of the survey was cyclo(Asp1-Asn2-Gln3-Tyr4-Ala5-Phe6-Phe7-Gln8-d-Phe 9-Pro10). The change of residues 6 and 7 resulted in a 42-fold increase in affinity and no increase in Vmax. As a substrate, this peptide displayed Michaelis-Menten kinetics at saturating ATP conditions. As an inhibitor, mixed inhibition was observed. A linear version of this peptide was 13-fold less potent an inhibitor than the cyclic peptide. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9647675     DOI: 10.1006/abbi.1998.0707

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  2 in total

1.  Tyrosine residues 654 and 670 in beta-catenin are crucial in regulation of Met-beta-catenin interactions.

Authors:  Gang Zeng; Udayan Apte; Amanda Micsenyi; Aaron Bell; Satdarshan P S Monga
Journal:  Exp Cell Res       Date:  2006-08-10       Impact factor: 3.905

2.  Small flexible structure for targeted delivery of therapeutic and imaging moieties in precision medicine.

Authors:  Shaofan Hu; Wei Wang; Yanling Zhang; Bingjie Li; Xiuchun Qiu; Chaoxia Zou; Henry Ran; Fujun Zhang; Shi Ke
Journal:  Oncotarget       Date:  2016-05-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.